JPS5913494B2 - シンキナインダンユウドウタイノセイゾウホウ - Google Patents

シンキナインダンユウドウタイノセイゾウホウ

Info

Publication number
JPS5913494B2
JPS5913494B2 JP50154485A JP15448575A JPS5913494B2 JP S5913494 B2 JPS5913494 B2 JP S5913494B2 JP 50154485 A JP50154485 A JP 50154485A JP 15448575 A JP15448575 A JP 15448575A JP S5913494 B2 JPS5913494 B2 JP S5913494B2
Authority
JP
Japan
Prior art keywords
reaction
formula
group
hydroxy
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP50154485A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5277045A (en
Inventor
浩巳 下村
久夫 山本
純基 勝部
明彦 杉江
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Priority to JP50154485A priority Critical patent/JPS5913494B2/ja
Priority to US05/748,539 priority patent/US4125731A/en
Priority to GB51997/76A priority patent/GB1538944A/en
Priority to FR7637887A priority patent/FR2336125A1/fr
Priority to NL7614010A priority patent/NL7614010A/xx
Priority to DE19762657761 priority patent/DE2657761A1/de
Priority to CA268,440A priority patent/CA1103269A/fr
Priority to SE7614435A priority patent/SE424634B/xx
Priority to DK578976A priority patent/DK578976A/da
Priority to BE173531A priority patent/BE849731A/fr
Priority to CH1621876A priority patent/CH628609A5/de
Publication of JPS5277045A publication Critical patent/JPS5277045A/ja
Publication of JPS5913494B2 publication Critical patent/JPS5913494B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/26Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/32Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by introduction of halogenated alkyl groups into ring compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/38Alcohols containing six-membered aromatic rings and other rings and having unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP50154485A 1975-12-23 1975-12-23 シンキナインダンユウドウタイノセイゾウホウ Expired JPS5913494B2 (ja)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP50154485A JPS5913494B2 (ja) 1975-12-23 1975-12-23 シンキナインダンユウドウタイノセイゾウホウ
US05/748,539 US4125731A (en) 1975-12-23 1976-12-08 Novel indan derivatives
GB51997/76A GB1538944A (en) 1975-12-23 1976-12-13 Indane compounds processes for producing them and pharmaceutical compositions containing them
FR7637887A FR2336125A1 (fr) 1975-12-23 1976-12-16 Nouveaux derives de l'indane
NL7614010A NL7614010A (nl) 1975-12-23 1976-12-17 Werkwijze voor de bereiding van nieuwe indaanderivaten.
DE19762657761 DE2657761A1 (de) 1975-12-23 1976-12-20 Indan-verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CA268,440A CA1103269A (fr) 1975-12-23 1976-12-21 Derives de l'indane
SE7614435A SE424634B (sv) 1975-12-23 1976-12-22 Analogiforfarande for framstellning av nya indanforeningar
DK578976A DK578976A (da) 1975-12-23 1976-12-22 Indanforbindelser samt deres fremstilling og anvendelse
BE173531A BE849731A (fr) 1975-12-23 1976-12-22 Nouveaux derives de l'indane
CH1621876A CH628609A5 (de) 1975-12-23 1976-12-22 Verfahren zur herstellung von indan-verbindungen.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50154485A JPS5913494B2 (ja) 1975-12-23 1975-12-23 シンキナインダンユウドウタイノセイゾウホウ

Publications (2)

Publication Number Publication Date
JPS5277045A JPS5277045A (en) 1977-06-29
JPS5913494B2 true JPS5913494B2 (ja) 1984-03-30

Family

ID=15585263

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50154485A Expired JPS5913494B2 (ja) 1975-12-23 1975-12-23 シンキナインダンユウドウタイノセイゾウホウ

Country Status (2)

Country Link
JP (1) JPS5913494B2 (fr)
BE (1) BE849731A (fr)

Also Published As

Publication number Publication date
JPS5277045A (en) 1977-06-29
BE849731A (fr) 1977-06-22

Similar Documents

Publication Publication Date Title
EP0163284B1 (fr) Chromanon-2-yl alkanols substitués et leurs dérivés
RS20070205A (sr) 5-supstituisani hinolin i izohinolin derivati, postupak njihove proizvodnje i njihova upotreba kao anti- inflamatornih sredstava
JPS6366832B2 (fr)
CA2135928A1 (fr) Alcools utilises comme agents d'ouverture des canaux potassiques et pour le traitement de l'incontinence urinaire
JPH0465816B2 (fr)
US3932467A (en) Process for the production of 2β-formyl 3α-protected hydroxy-5-oxocyclopentane-1α-heptanoic acids and esters corresponding
JPS6341909B2 (fr)
JPS5913493B2 (ja) 新規ビシクロ〔2,2,1〕ヘプテン誘導体の製造法
US3758511A (en) Preparation of d,1-zearalenones
JPS5933578B2 (ja) 新規なインダン誘導体
US3925487A (en) Substituted diphenyl ethene
JPS5913491B2 (ja) シンキナインダンユウドウタイノセイゾウホウ
JPS60188336A (ja) 新規カルバサイクリン、その製法及びこれを含有する細胞保護剤
US3803219A (en) Novel cyclopentene derivatives
JPS5913492B2 (ja) 新規なインダン誘導体の製造法
JPH0222071B2 (fr)
US3960895A (en) Aryl ketals of polycyclic oxo compounds and processes
JPH0119371B2 (fr)
JPS598249B2 (ja) カルコン類の合成法
JPS5913490B2 (ja) 新規ビシクロ〔2,2,1〕ヘプテン誘導体の製造法
CA1103269A (fr) Derives de l'indane
US3948951A (en) Aryl ketals of 1-chloro-4-oxo-pentane
SU383287A1 (ru) СПОСОБ ПОЛУЧЕНИЯ 3-ЦИКЛОПЕНТИЛОВОГО ЭФИРА 7а-МЕТИЛ-17а-ЭТИНИЛЭСТРАДИОЛА1Известно, что конденсацию ацетилена с ка.р- ^бонильными соединени ми можно осуществл ть с помощью производных щелочных металлов. Применение известной реакции позволило получить новое соединение, обладаю1цее ценными свойствами.=0подвергают реакции обмена с ацетиленметал- лическим соединением, преимущественно с соединением ацетилена по Гринь ру или с ацетиленидом щелочного металла, с выделе-5 нием целевого продукта известными приемами. Так на кетон указанной формулы можно воздействовать ацетиленом в присутствии ал- когол та щелочного металла, например этила- ,та натри или третичного амилата натри .10 Эту реакцию провод т обычным способом при желании в присутствии катализатора в среде органического растворител , например пизкокип щего алканола (этанол, бутанол, диметиловый гликолевый эфир) или углеводо-15 рода ('бензол, толуол, циклогексан или цикло- пентан), или диметилсульфоксида, или жидкого аммиака.
KR810001248B1 (ko) 시클로펜탄올의 락톤유도체의 제조방법
US3994926A (en) Aryl ketals of polycyclic oxo compounds and processes